Nothing Special   »   [go: up one dir, main page]

PL1930416T3 - Nowa rekombinowana cząstka podobna do ludzkiego wirusa zapalenia wątroby typu C i sposób jej wytwarzania - Google Patents

Nowa rekombinowana cząstka podobna do ludzkiego wirusa zapalenia wątroby typu C i sposób jej wytwarzania

Info

Publication number
PL1930416T3
PL1930416T3 PL06810937T PL06810937T PL1930416T3 PL 1930416 T3 PL1930416 T3 PL 1930416T3 PL 06810937 T PL06810937 T PL 06810937T PL 06810937 T PL06810937 T PL 06810937T PL 1930416 T3 PL1930416 T3 PL 1930416T3
Authority
PL
Poland
Prior art keywords
virus
particle
producing
same
recombinant human
Prior art date
Application number
PL06810937T
Other languages
English (en)
Inventor
Jun-Ichi Tanabe
Saburo Sone
Takaji Wakita
Koji Ishii
Ryosuke Suzuki
Tetsuro Suzuki
Tatsuo Miyamura
Original Assignee
Japan As Represented By The Director General Of Nat Institute Of Infectious Diseases
Tokyo Metropolitan Inst Medical Science
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan As Represented By The Director General Of Nat Institute Of Infectious Diseases, Tokyo Metropolitan Inst Medical Science, Toray Industries filed Critical Japan As Represented By The Director General Of Nat Institute Of Infectious Diseases
Publication of PL1930416T3 publication Critical patent/PL1930416T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24223—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24241—Use of virus, viral particle or viral elements as a vector
    • C12N2770/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24251—Methods of production or purification of viral material
    • C12N2770/24252—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL06810937T 2005-09-30 2006-09-29 Nowa rekombinowana cząstka podobna do ludzkiego wirusa zapalenia wątroby typu C i sposób jej wytwarzania PL1930416T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005287825 2005-09-30
PCT/JP2006/319573 WO2007037429A1 (ja) 2005-09-30 2006-09-29 新規組換え型ヒトｃ型肝炎ウイルス様粒子とその産生方法
EP06810937A EP1930416B1 (en) 2005-09-30 2006-09-29 Novel recombinant human hepatitis c virus-like particle and method for producing the same

Publications (1)

Publication Number Publication Date
PL1930416T3 true PL1930416T3 (pl) 2012-05-31

Family

ID=37899849

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06810937T PL1930416T3 (pl) 2005-09-30 2006-09-29 Nowa rekombinowana cząstka podobna do ludzkiego wirusa zapalenia wątroby typu C i sposób jej wytwarzania

Country Status (11)

Country Link
US (1) US8183044B2 (pl)
EP (1) EP1930416B1 (pl)
JP (1) JP5035985B2 (pl)
KR (1) KR101416143B1 (pl)
CN (1) CN101278042B (pl)
AU (1) AU2006295716B2 (pl)
CA (1) CA2624130C (pl)
ES (1) ES2376354T3 (pl)
PL (1) PL1930416T3 (pl)
PT (1) PT1930416E (pl)
WO (1) WO2007037429A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8945584B2 (en) 2007-04-13 2015-02-03 Hvidovre Hospital Cell culture system of a hepatitis C genotype 3a and 2a chimera
US8454974B2 (en) 2007-04-13 2013-06-04 Hvidovre Hospital Adaptive mutations allow establishment of JFH1-based cell culture systems for hepatitis C virus genotype 4A
WO2008141651A1 (en) 2007-05-18 2008-11-27 Hvidovre Hospital Efficient cell culture system for hepatitis c virus genotype 5a
US8563706B2 (en) 2007-12-20 2013-10-22 Hvidovre Hospital Efficient cell culture system for hepatitis C virus genotype 1A and 1B
US8569472B2 (en) 2007-12-20 2013-10-29 Hvidovre Hospital Efficient cell culture system for hepatitis C virus genotype 6A
WO2010017819A1 (en) 2008-08-15 2010-02-18 Hvidovre Hospital EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a
US8663653B2 (en) 2008-08-15 2014-03-04 Hvidovre Hospital Efficient cell culture system for hepatitis C virus genotype 2B
EP2344647A1 (en) 2008-10-03 2011-07-20 Hvidovre Hospital Hepatitis c virus expressing reporter tagged ns5a protein
US10174317B2 (en) 2014-02-13 2019-01-08 Synthetic Genomics, Inc. Recombinant RNA particles and methods of use
CN110346239B (zh) * 2019-07-10 2022-02-11 国家纳米科学中心 一种纳米材料密度的检测方法
WO2022152939A1 (en) 2021-01-18 2022-07-21 Conserv Bioscience Limited Coronavirus immunogenic compositions, methods and uses thereof
CN117737089B (zh) * 2023-12-21 2024-11-01 昆明理工大学 一种3b型丙肝病毒亚基因组复制子及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4880116B2 (ja) 2000-12-01 2012-02-22 財団法人 東京都医学総合研究所 劇症ｃ型肝炎ウイルス株の遺伝子
EP1537206B1 (en) 2002-09-13 2009-05-06 Institut National De La Sante Et De La Recherche Medicale (Inserm) Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins
EP1578956A4 (en) * 2002-11-13 2006-02-08 Univ Washington HIGHLY PERMISSIVE CELL LINES FOR REPLICATION OF HEPATITIS C VIRUS RNA
CA2558685C (en) * 2004-02-20 2014-08-12 Tokyo Metropolitan Organization For Medical Research Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle
CA2603711C (en) * 2005-03-04 2013-06-18 The Rockefeller University Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof

Also Published As

Publication number Publication date
CA2624130C (en) 2015-02-03
CA2624130A1 (en) 2007-04-05
EP1930416B1 (en) 2011-12-14
EP1930416A4 (en) 2009-03-11
CN101278042A (zh) 2008-10-01
CN101278042B (zh) 2011-12-14
EP1930416A1 (en) 2008-06-11
AU2006295716A1 (en) 2007-04-05
JPWO2007037429A1 (ja) 2009-04-16
AU2006295716B2 (en) 2011-11-03
WO2007037429A1 (ja) 2007-04-05
KR101416143B1 (ko) 2014-07-08
JP5035985B2 (ja) 2012-09-26
ES2376354T3 (es) 2012-03-13
KR20080056194A (ko) 2008-06-20
US8183044B2 (en) 2012-05-22
US20090221028A1 (en) 2009-09-03
PT1930416E (pt) 2012-02-02

Similar Documents

Publication Publication Date Title
PL1930416T3 (pl) Nowa rekombinowana cząstka podobna do ludzkiego wirusa zapalenia wątroby typu C i sposób jej wytwarzania
EP1863941A4 (en) INFECTIOUS CHIMERIC HEPATITIS C VIRUS, METHOD FOR THE PRODUCTION THEREOF AND USE METHOD THEREFOR
EP1947121A4 (en) HEAT-EXPANDABLE MICROBALL AND MANUFACTURING METHOD THEREFOR
EP1872711A4 (en) SOLID COSMETIC PIN AND METHOD FOR THE PRODUCTION THEREOF
GB2473771B (en) Metal powders and methods for producing the same
IL190775A0 (en) Influenza virus-like particles and vaccines containing the same
HK1110483A1 (en) Wig and process for producing the same
TWI350219B (en) Copper fine particles and method for preparing the same
EP1945159A4 (en) MAGNETIC NANO-SCALE PARTICLE COMPOSITIONS AND ASSOCIATED THERAPEUTIC METHODS
EP1783096A4 (en) ALPHA-SIALON POWDER AND PROCESS FOR PRODUCING THE SAME
IL186260A0 (en) Alunite compound particle, process for producing the same and use thereof
EP1935916A4 (en) POLYARYLENE AND METHOD FOR PRODUCING THE SAME
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
GB2429974B (en) Method for producing particles,particles,and sintered body
EP1758925A4 (en) PRODUCTION OF A RECOMBINANT ICOSAHEDRIC VIRUS LIKE PARTICLE
GB2422344A8 (en) Rapid prototyping unsing infrared sintering
EP1958489A4 (en) PARTICLE ACCOMMODATION AND METHOD THEREFOR
EP1841581A4 (en) COMPOSITE MATERIALS AND METHOD FOR THE PRODUCTION AND USE THEREOF
EP1778587A4 (en) CERIUM OXIDE POWDER AND PROCESS FOR PRODUCING THE SAME
EP1959024A4 (en) CO-BASED ALLOY AND PROCESS FOR PRODUCING THE SAME
EP1864684A4 (en) ARTIFICIAL BONE AND PROCESS FOR PRODUCING THE SAME
EP1832188A4 (en) WIG AND WIG MANUFACTURING METHOD
EP1876144A4 (en) COMPOSITE OXIDE PARTICLES TITANIUM SILICA OXIDE.
EP1640006A4 (en) PARTICLES WITH DELAYED MEDICAMENT RELIEF AND MANUFACTURING METHOD THEREFOR
EP1947137A4 (en) BIODEGRADABLE PARTICLES AND MANUFACTURING METHOD THEREFOR